Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIOngoingD-0910-2016

Drug recall · June 8, 2016

LGD-Xtreme recall

Why: Marketed Without An Approved NDA/ANDA: Contains an unapproved drug, ligandrol LGD-4033

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

LGD-Xtreme (ligandrol LGD-4033),capsules, 3 mg, 90-count bottle, Manufactured for Continuum Labs, Fort Lauderdale, FL

Lots / codes

Lot # 21511166, Exp 11/18

Quantity
3,319 bottles
Company
Invisiblu International LLC, Fort Lauderdale, FL
Distribution
Nationwide and Brazil.
Initiated
March 31, 2016 · Voluntary: Firm initiated
Classified
May 27, 2016
Reported
June 8, 2016
How notified
Press Release

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.